IL-34 exacerbates pathogenic features of Alzheimer’s disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice

dc.contributor.authorHo, Anny
dc.contributor.authorNgala, Bidii
dc.contributor.authorYamada, Chiaki
dc.contributor.authorGarcia, Christopher
dc.contributor.authorDuarte, Carolina
dc.contributor.authorAkkaoui, Juliet
dc.contributor.authorCiolac, Dumitru
dc.contributor.authorNusbaum, Amilia
dc.contributor.authorKochen, William
dc.contributor.authorEfremova, Daniela
dc.contributor.authorGroppa, Stanislav
dc.contributor.authorNathanson, Lubov
dc.contributor.authorBissel, Stephanie
dc.contributor.authorOblak, Adrian
dc.contributor.authorKacena, Melissa A.
dc.contributor.authorMovila, Alexandru
dc.contributor.departmentBiomedical and Applied Sciences, School of Dentistry
dc.date.accessioned2024-05-10T09:11:18Z
dc.date.available2024-05-10T09:11:18Z
dc.date.issued2023
dc.description.abstractHallmark features of Alzheimer’s disease (AD) include elevated accumulation of aggregated Aβ40 and Aβ42 peptides, hyperphosphorylated Tau (p-Tau), and neuroinflammation. Emerging evidence indicated that interleukin-34 (IL-34) contributes to AD and inflammatory osteolysis via the colony-stimulating factor-1 receptor (CSF-1r). In addition, CSF-1r is also activated by macrophage colony-stimulating factor-1 (M-CSF). While the role of M-CSF in bone physiology and pathology is well addressed, it remains controversial whether IL-34-mediated signaling promotes osteolysis, neurodegeneration, and neuroinflammation in relation to AD. In this study, we injected 3x-Tg mice with mouse recombinant IL-34 protein over the calvaria bone every other day for 42 days. Then, behavioral changes, brain pathology, and calvaria osteolysis were evaluated using various behavioral maze and histological assays. We demonstrated that IL-34 administration dramatically elevated AD-like anxiety and memory loss, pathogenic amyloidogenesis, p-Tau, and RAGE expression in female 3x-Tg mice. Furthermore, IL-34 delivery promoted calvaria inflammatory osteolysis compared to the control group. In addition, we also compared the effects of IL-34 and M-CSF on macrophages, microglia, and RANKL-mediated osteoclastogenesis in relation to AD pathology in vitro. We observed that IL-34-exposed SIM-A9 microglia and 3x-Tg bone marrow-derived macrophages released significantly elevated amounts of pro-inflammatory cytokines, TNF-α, IL-1β, and IL-6, compared to M-CSF treatment in vitro. Furthermore, IL-34, but not M-CSF, elevated RANKL-primed osteoclastogenesis in the presence of Aβ40 and Aβ42 peptides in bone marrow derived macrophages isolated from female 3x-Tg mice. Collectively, our data indicated that IL-34 elevates AD-like features, including behavioral changes and neuroinflammation, as well as osteoclastogenesis in female 3x-Tg mice.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationHo A, Ngala B, Yamada C, et al. IL-34 exacerbates pathogenic features of Alzheimer's disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice. Biomed Pharmacother. 2023;166:115435. doi:10.1016/j.biopha.2023.115435
dc.identifier.urihttps://hdl.handle.net/1805/40629
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.biopha.2023.115435
dc.relation.journalBiomedicine & Pharmacotherapy
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectInterleukin-34
dc.subjectAlzheimer’s Disease
dc.subjectOsteolysis
dc.subjectNeuroinflammation
dc.subjectRANKL-mediated osteoclastogenesis
dc.subjectCognitive behavior
dc.titleIL-34 exacerbates pathogenic features of Alzheimer’s disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ho2023IL-34-AAM.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: